April 20, 2024 Comments Off on New patent expiration for Optinose Us drug XHANCE Posted in: Uncategorized
Annual Drug Patent Expirations for XHANCE Xhance is a drug marketed by Optinose Us Inc and is included in one NDA. It is available from one supplier. There are fourteen…
Source
April 20, 2024 Comments Off on New tentative approval for Xiamen Lp drug topiramate Posted in: Tentative Approval [](//www.DrugPatentWatch.com/p/preview/generic-api/topiramate?utm_medium=dpw_wp_blog&utm_campaign=dpw_wp_blog&utm_source=dpw_wp_blog) Topiramate is the generic in…
